← All stocks

CURIS INC

CRIS Net selling
CIK 0001108205 #5492 in the set updated 21 Sep 2026
Bought (120 mo)
$82.99K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.27M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.27M
26 of 26 sales
Net
−$1.19M
−$1.19M against sales at will

By person

12 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
MCNAB JAMES R
Director
$1.10M (13)
−$1.10M
929,688
$510.12K
−32.6%
Dentzer James E
President & CEO
$92.38K (8)
−$92.38K
148,730
$81.61K
Fattaey Ali Ph.D.
President & CEO
$53.00K (1)
+$53.00K
322,140
$176.76K
+388.9%
GREENACRE MARTYN D
Director
$19.47K (1)
−$19.47K
26,089
$14.32K
Kunkel Lori Anne
Director
$15.58K (1)
−$15.58K
22,200
$12.18K
KAITIN KENNETH I
Director
$5.49K (1)
$15.59K (1)
−$10.10K
11,407
$6.26K
Martell Robert
Head of Research & Development
$5.90K (1)
−$5.90K
23,027
$12.63K
Rubin Marc
Director
$24.50K (1)
$19.48K (1)
+$5.02K
28,108
$15.42K
Tuck David
Chief Medical Officer
169,424
$92.96K
+374.9%
Duvall Diantha
CFO
77,707
$42.64K
+603.8%
Zung Jonathan B.
CDO
66,667
$36.58K
Hamdy Ahmed MD
CMO
66,667
$36.58K

No percentages here. This company's share count has moved by a factor of 19.1 over the window, from 2,090,077 to 39,978,693 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
KAITIN KENNETH I
31 Mar 2026
Director
Buy
10,000
$0.55
$5.49K
Rubin Marc
16 Nov 2017
Director
Buy
25,000
$0.98
$24.50K
Fattaey Ali Ph.D.
15 Nov 2017
President & CEO
Buy
50,000
$1.06
$53.00K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,894,109
Sales filed before the plan box existed 26
History held since 9 Sep 2016